<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Glob Cardiol Sci Pract</journal-id>
<journal-id journal-id-type="iso-abbrev">Glob Cardiol Sci Pract</journal-id>
<journal-id journal-id-type="pmc">GCSP</journal-id>
<journal-id journal-id-type="publisher-id">GCSP</journal-id>
<journal-title-group>
<journal-title>Global Cardiology Science &amp; Practice</journal-title>
</journal-title-group>
<issn pub-type="epub">2305-7823</issn>
<publisher>
<publisher-name>Bloomsbury Qatar Foundation Journals</publisher-name>
<publisher-loc>Qatar</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26566530</article-id>
<article-id pub-id-type="pmc">4625210</article-id>
<article-id pub-id-type="publisher-id">gcsp.2015.39</article-id>
<article-id pub-id-type="doi">10.5339/gcsp.2015.39</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetics of channelopathies associated with sudden cardiac death</article-title>
<alt-title alt-title-type="rrh">Global Cardiology Science and Practice</alt-title>
<alt-title alt-title-type="lrh">Campuzano et al</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Campuzano</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="FN0001">
<sup>#</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarquella-Brugada</surname>
<given-names>Georgia</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="FN0001">
<sup>#</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brugada</surname>
<given-names>Ramon</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brugada</surname>
<given-names>Josep</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref rid="caf1">*</xref>
<xref ref-type="corresp" rid="caf1">
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup>Cardiovascular Genetics Center, University of Girona – IDIBGI, Spain</aff>
<aff id="aff2"><sup>2</sup>Department of Medical Sciences, School of Medicine, University of Girona, Spain</aff>
<aff id="aff3"><sup>3</sup>Unit of Arrhythmias, Hospital Sant Joan de Deu, University of Barcelona, Spain</aff>
<aff id="aff4"><sup>4</sup>Unit of Arrhythmias, Hospital Clinic de Barcelona, University of Barcelona, Spain</aff>
<author-notes>
<corresp id="caf1"><sup>*</sup>E-mail: <email xlink:href="josep@brugada.org">josep@brugada.org</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>2015</volume>
<issue>3</issue>
<elocation-id>39</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>3</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>6</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2015 Campuzano, Sarquella-Brugada, Brugada, Brugada, licensee Bloomsbury Qatar Foundation Journals.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Brown, licensee Bloomsbury Qatar Foundation Journals.</copyright-holder>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Recent technological advances in cardiology have resulted in new guidelines for the diagnosis, treatment and prevention of diseases. Despite these improvements, sudden death remains one of the main challenges to clinicians because the majority of diseases associated with sudden cardiac death are characterized by incomplete penetrance and variable expressivity. Hence, patients may be unaware of their illness, and physical activity can be the trigger for syncope as first symptom of the disease. Most common causes of sudden cardiac death are congenital alterations and structural heart diseases, although a significant number remain unexplained after comprehensive autopsy. In these unresolved cases, channelopathies are considered the first potential cause of death. Since all these diseases are of genetic origin, family members could be at risk, despite being asymptomatic. Genetics has also benefited from technological advances, and genetic testing has been incorporated into the sudden death field, identifying the cause in clinically affected patients, asymptomatic family members and post-mortem cases without conclusive diagnosis. This review focuses on recent advances in the genetics of channelopathies associated with sudden cardiac death.</p>
</abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>Sudden cardiac death</kwd>
<kwd>arrhythmias</kwd>
<kwd>channelopathies</kwd>
<kwd>genetics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Sudden death (SD) is defined as a “<italic>natural and unexpected event that occurs within the first hour after onset of symptoms in an apparently healthy subject or whose disease was not severe enough to predict a fatal outcome, and in which a thorough postmortem examination fails to demonstrate an adequate cause of death</italic>”.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> Nearly 85% of all SD are of cardiac origin, called sudden cardiac death (SCD). SCD is a leading cause of death in Western countries, and despite a huge number of deaths it remains without a definitive diagnosis.<sup><xref ref-type="bibr" rid="bib2">2</xref></sup>
</p>
<p>In the last 50 years, technological advances in biomedicine have improved diagnosis. Genetics has been one of the main fields to take advantage of this technological progress. Cardiology has incorporated these advances in genetics, identifying several new genes responsible for disease associated with SCD. As a consequence, genetic testing has been progressively incorporated into clinical diagnoses, identifying the cause of the disease in clinically affected patients, unresolved post-mortem cases and even in asymptomatic individuals who - despite being asymptomatic - are at risk of SCD because they carry the genetic alteration responsible for the disease.<sup><xref ref-type="bibr" rid="bib3">3</xref></sup> Therefore, genetics has been incorporated into current clinical guidelines on SCD.</p>
<p>There are many types of heart disease in which genetic factors - with or without accompanying structural heart disease - may predispose an individual to arrhythmias or SCD. Examples include coronary heart disease, heart failure, congenital cardiac channelopathies, cardiomyopathies, coronary artery anomalies and/or aortic root dissection.<sup><xref ref-type="bibr" rid="bib4">4</xref></sup> Currently, nearly 80% of SCD cases in individuals over 55 years old are a consequence of coronary heart disease. However, SD in the young-adult population ( &lt;  35 years old) is often caused by arrhythmic syndromes without structural heart disease.<sup><xref ref-type="bibr" rid="bib5">5</xref></sup> In addition, in young population ( &lt;  15 years old), nearly 40% of SD have a potential arrhythmogenic origin.<sup><xref ref-type="bibr" rid="bib6">6</xref></sup>
</p>
</sec>
<sec>
<title>Channelopathies</title>
<p>Channelopathies are a group of cardiac diseases characterized by a structurally normal heart leading to arrhythmogenesis, syncope and SCD.<sup><xref ref-type="bibr" rid="bib7">7</xref></sup> These diseases are of genetic origin and within affected families, variable expressivity and incomplete phenotype of several members are frequent. Some of these diseases are not accompanied by changes in the electrocardiogram (ECG), which makes them more difficult to diagnose. Given that these diseases are caused by a genetic alteration, genetic testing can contribute substantially both to the diagnosis of affected patients and to prevention, with the identification of asymptomatic individuals at risk.<sup><xref ref-type="bibr" rid="bib8">8</xref></sup> Recent advances in the field of genetics have identified several genetic alterations in genes encoding ion channel proteins or associated proteins.<sup><xref ref-type="bibr" rid="bib9">9</xref></sup>
</p>
<p>Ion channels are proteins located in the membrane of the myocyte, which allow the movement of ions in and out, in order to maintain ion balance. A complex coordination of open/close channels in response to the electric gradient gives rise to the cardiac action potential. Currently, most of the aspects of genetic alteration associated with SCD have been identified in sodium, potassium and calcium channels. Several other elements are also necessary to achieve a coordinated cardiac activity,<sup><xref ref-type="bibr" rid="bib10">10</xref></sup> but these are less well understood. If ion channel proteins or associated proteins are defective, cardiac activity is altered inducing arrhythmogenesis that may lead to SCD.</p>
<p>In general, depending on which ion channel is affected, different syndromes will be present. Nevertheless, the same syndrome may show a certain degree of overlap with different types of channel being affected. In addition, the interaction of genetic factors and environment as a phenotype modifier<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> is well documented. Finally, and despite the tremendous advances in genetics of channelopathies associated with SCD, a large proportion of families remain without a genetic diagnosis after comprehensive genetic analysis.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> Integration of knowledge of all these facts will lead to key information for stratifying risk of SCD.</p>
</sec>
<sec>
<title>Sodium channel and associated proteins</title>
<p>Several genetic alterations in sodium channels have been identified as causative of diseases associated with SCD (<xref ref-type="table" rid="tbl1">Table 1</xref>). Different genetic defects in the same gene can give rise to different phenotypes, and even combinations of phenotypes.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> Among the diseases identified, there are two main ion channel diseases: Long QT syndrome (LQT) and Brugada Syndrome (BrS).</p>
<sec>
<title>Long QT syndrome</title>
<p>Long QT syndrome characterized by prolongation of the QT interval in the ECG (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The clinical presentation can be variable, ranging from asymptomatic patients to syncope, ventricular arrhythmias, typically <italic>torsade de pointes</italic>, and SCD. LQT is one of the leading causes of sudden death among young people.<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> So far, more than 600 genetic alterations have been reported as pathogenic. Some of these are localized in 3 sodium genes (<italic>SCN5A, SCN4B</italic> and <italic>SCN1B</italic>) and 2 associated-proteins (Caveolin3 and Syntrophin)<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<p>Pathogenic variance in <italic>SCN5A</italic> (LQT syndrome type 3) causes a functional defect based on incomplete inactivation of the channel, thereby allowing continued entry of sodium ions into the cell during repolarization and leading to enhanced function. Usually, arrhythmias occur at rest.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> In the case of the <italic>SCN4B</italic> sodium gene, the beta sub-unit (Na<sub>v</sub>β4) of the sodium channel causes a negative change in the sodium dependent voltage in the activation channel.<sup><xref ref-type="bibr" rid="bib16">16</xref></sup> Recently, a pathogenic variant has also been identified in the <italic>SCN1B</italic> gene as responsible of LQT syndrome. It encodes two Na<sub>v</sub>β1 sub-unit cardiac isoforms: Na<sub>v</sub>β1 isoform a, and Na<sub>v</sub>β1 isoform b.<sup><xref ref-type="bibr" rid="bib17">17</xref></sup> If we look at sodium associated proteins, the <italic>CAV3</italic> gene encodes for caveolin-3, which is the main protein that forms the caveolae in cardiac and skeletal muscle. Pathogenic variants in the <italic>CAV3</italic> gene have been associated with LQT Syndrome due to caveolin-3 interacting with Kir2.1, and genetic alterations decreasing I<sub>K1</sub> density.<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> The other sodium-associated protein is α1-Syntrophin, encoded by the <italic>SNTA1</italic> gene. α1-Syntrophin is one of the dystrophin-associated proteins, and contains multiple protein interacting motifs. A total of 3 pathogenic variants of <italic>SNTA</italic>
<sub><italic>1</italic></sub> associated with LQT syndrome have been reported.<sup><xref ref-type="bibr" rid="bib19">19</xref></sup>
</p>
</sec>
<sec>
<title>Brugada syndrome</title>
<p>This cardiac entity is characterized by ST elevation at leads V1-3 in the ECG, leading to ventricular arrhythmias and SCD (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The mean age of onset of events is around 40 years, mainly in men.<sup><xref ref-type="bibr" rid="bib20">20</xref></sup> Most of the pathogenic variants have been identified in sodium genes, although potassium and calcium genes have also been also associated with BrS (<italic>SCN1B, SCN2B, SCN3B, SCN10A, GPD1-L, RANGRF, SLMAP, PKP2, KCNE3, KCNJ8, KCND3, KCNE5, HCN4, ABCC9, CACNA1C, CACNB2b, CACNA2D1,</italic> and <italic>TRPM4</italic>) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). All these genes together are responsible for nearly 35% of BrS cases.<sup><xref ref-type="bibr" rid="bib21">21</xref></sup> Regarding sodium channels and associated proteins (<italic>SCN5A, GPD1-L, SCN1B, SCN3B, SCN2B, SCN10A, PKP2, RANGRF,</italic> and <italic>SLMAP</italic>), the <italic>SCN5A</italic> gene alone is responsible for nearly 25% of BrS cases. This gene encodes the cardiac sodium channel Nav1.5, and is responsible for phase O of the cardiac action potential. Pathogenic variations in the <italic>SCN5A</italic> gene induce a loss of function.<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> Other pathogenic variations have been published in <italic>SCN1B, SCN2B,</italic> and <italic>SCN3B</italic> encoding beta subunits that modify Nav1.5 (increasing or decreasing I<sub>Na</sub>). The <italic>SCN1B</italic> gene encodes the β1 subunit of the cardiac sodium channel conducting the INa current. In the heart, the biophysical function of β1 subunits and of β1b splicing variants is to modify the function of Nav1.5, by increasing the I<sub>Na</sub>.<sup><xref ref-type="bibr" rid="bib23">23</xref></sup> The <italic>SCN2B</italic> gene encodes the β2 sodium channel subunit,<sup><xref ref-type="bibr" rid="bib24">24</xref></sup> and the <italic>SCN3B</italic> gene encodes the β3 subunit of the cardiac sodium channel conducting the I<sub>Na</sub> current. In the heart the function of the β3 subunit is to modify the function of Nav1.5 by increasing the Ina, similarly to the β1 subunit, but with different kinetics.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> Recently, the <italic>SCN10A</italic> gene, a neuronal sodium channel gene encoding Nav1.8, has also been found to modulate <italic>SCN5A</italic> expression and the electrical function of the heart,<sup><xref ref-type="bibr" rid="bib26">26</xref></sup> and pathogenic variants of the <italic>GPD1-L</italic> gene have been implicated in reducing both the surface membrane expression and the inward sodium current.<sup><xref ref-type="bibr" rid="bib27">27</xref></sup> Other studies have shown the <italic>RANGRF</italic> gene to impair the trafficking of Nav1.5 to the membrane, leading to I<sub>Na</sub> reduction and clinical manifestation of BrS.<sup><xref ref-type="bibr" rid="bib28">28</xref></sup> In 2012, a pathogenic variant was identified in <italic>SLMAP</italic>. This gene encodes the sarcolemmal membrane-associated protein which is localized at the T-tubules and sarcoplasmic reticulum, and it causes BrS by modulating the intracellular trafficking of the Nav1.5 channel.<sup><xref ref-type="bibr" rid="bib29">29</xref></sup> Finally, a pathogenic variant has been identified in <italic>PKP2</italic> (plakophilin-2 protein). This is a desmosomal gene and correlation between the loss of expression of plakophilin-2 and reduced I<sub>Na</sub> has been identified in BrS patients.<sup><xref ref-type="bibr" rid="bib30">30</xref></sup>
</p>
</sec>
</sec>
<sec>
<title>Potassium channel and associated proteins</title>
<p>Potassium channels are key participants in the cardiac action potential, and genetic alterations in these channels or associated proteins may lead to dysfunction and potassium imbalance<sup><xref ref-type="bibr" rid="bib31">31</xref></sup> (<xref ref-type="table" rid="tbl1">Table 1</xref>). There are 4 main channelopathies associated with SCD: LQT syndrome, short QT syndrome (SQT), BrS and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).</p>
<sec>
<title>Long QT Syndrome</title>
<p>As already mentioned, LQT syndrome is usually caused by repolarization abnormalities with implication of the potassium channels (Iks, Ikr, Iki). Pathogenic genetic variants identified in potassium genes lead to a loss of function; this in turn gives rise to a decrease in the release of potassium, inducing the channels to remain open for longer and the QT interval to be prolonged due to a longer ventricular repolarization time.<sup><xref ref-type="bibr" rid="bib32">32</xref></sup>
</p>
<p>Currently, several pathogenic genetic alterations have been reported in 6 different potassium channel genes (<italic>KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2,</italic> and <italic>KCNJ5</italic>), and one associated protein (<italic>AKAP9</italic>), accounting for 50% to 60% of the clinically diagnosed LQT syndrome cases<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The main gene associated with LQT syndrome is <italic>KCNQ1,</italic> with pathogenic variants responsible for 40% to 50% of cases of prolonged QT interval, giving rise to type 1 long QT syndrome.<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> This protein binds to the protein encoded by the <italic>KCNE1</italic> gene (<italic>minK</italic>) to form the Iks functional complex.<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> Around 10 different pathogenic variants have been identified in <italic>KCNE1.</italic> Another disease-associated gene is <italic>KCNH2,</italic> which encodes a subunit of the Ikr complex; This Ikr complex is the most important inducer of fast repolarization in phase 3 of Cardiac Action Potential. Pathogenic variants in <italic>KCNH2</italic> lead to loss of function in the Ikr channel, and account for 35% to 45% of LQT syndrome cases.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> Pathogenic variants of <italic>KCNE2</italic> similarly lead to loss of channel function, as do those in the <italic>KCNJ2</italic> gene, which encodes Ik1 (Kir2.1) protein (Tawil-Anderson syndrome).<sup><xref ref-type="bibr" rid="bib36">36</xref></sup> However, the incidence of this latter gene variant in the population is very low and rarely associated with SCD. Other potassium genes associated with LQT syndrome include <italic>KCNJ5</italic>, which encodes for Kir3.4 channel (also called GIRK4). <italic>KCNJ5</italic> forms homomeric channels or functional heteromeric channels with other Kir3.x, channels responsible for G protein-coupled inwardly rectifying potassium channel current (IKACh), mainly expressed in the sinoatrial node, sinoventricular node and atria.<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> Finally, a potassium-associated protein identified in LQT syndrome patients is A-kinase-anchoring proteins (AKAPs) 9, which is a scaffolding protein that determines the localization of protein kinase A (PKA) and other proteins that regulate the PKA (phosphatases or other kinases). It is encoded by the <italic>AKAP9</italic> gene. Few pathogenic variants have been reported in this gene, the AP duration is prolonged due to a reduction of the cAMP-dependent phosphorylation of Kv7.1, and reduction in cAMP stimulation response occurs.<sup><xref ref-type="bibr" rid="bib38">38</xref></sup>
</p>
</sec>
<sec>
<title>Short QT syndrome</title>
<p>Short QT syndrome (SQT) is a rare and lethal cardiac entity characterized by no structural heart alterations and a short QT interval in the ECG ( &lt; 330 ms). It also shows absent or minimal ST segments, an interval from J point to T wave peak (Jp-Tp) measured in the precordial lead with the T wave of greatest amplitude &lt; 120 ms, and possible tall T waves with narrow base similar to the T wave of moderate hyperkalemia (“desert tent T waves”). In addition, you have a frequent early repolarization pattern, prolongation of T peak-T end interval, and a possible presence of prominent U waves (<xref ref-type="fig" rid="fig1">Figure 1</xref>). All these events may lead to ventricular arrhythmias, syncope and SCD at an early age, although asymptomatic patients have also been reported.<sup><xref ref-type="bibr" rid="bib39">39</xref></sup>
</p>
<p>Currently, these genetic alterations have been identified in 6 different genes (<italic>KCNQ1, KCNJ2, KCNH2, CACNA1C, CACNB2,</italic> and <italic>CACNA2D1</italic>) (<xref ref-type="fig" rid="fig2">Figure 2</xref>), which follow an autosomal dominant pattern of inheritance, demonstrate high penetrance and are responsible for nearly 60% of clinically diagnosed cases.<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> Type 1 short QT syndrome has been associated with genetic variants in <italic>KCNH2</italic> that induce a fast activation of potassium currents, with enhanced Ikr function and shortened ventricular action potentials. In this type, cardiac events are generally associated with adrenergic situations (noise or exercise), although cases of cardiac events at rest have also been published.<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> Type 2 short QT syndrome has been linked to genetic variant in <italic>KCNQ1</italic>, which enhances the function of the potassium channel, leading to a shortening of the action potential. In this gene, a particularly highly malignant entity characterized by bradycardia <italic>in uterus</italic> and SQT and Atrial Fibrillation (AF) in the neonatal period has been reported.<sup><xref ref-type="bibr" rid="bib42">42</xref></sup> Type 3 short QT syndrome is caused by genetic variants in <italic>KCNJ2</italic>, leading to an acceleration of the phase 3 action potential.<sup><xref ref-type="bibr" rid="bib43">43</xref></sup>
</p>
</sec>
<sec>
<title>Brugada syndrome</title>
<p>Several pathogenic variants have been identified in potassium channels in BrS families (<italic>KCNE3, KCNJ8, KCND3, KCNE5, HCN4</italic> and <italic>ABCC9</italic>). In 2011, the first evidence implicating a novel gain-of-function pathogenic variant in <italic>KCND3</italic> associated with BrS was published. This gene encodes a voltage-gated potassium channel which is prominent in the repolarization phase of the action potential.<sup><xref ref-type="bibr" rid="bib44">44</xref></sup> Pathogenic variants associated with BrS have been also identified in the <italic>KCNE3</italic> gene. This gene encodes MiRP2, a regulatory β subunit of the transient outward potassium channel I<sub>to</sub>, which is one of five homologous auxiliary β subunits (KCNE peptides) of voltage-gated potassium ion channels.<sup><xref ref-type="bibr" rid="bib45">45</xref></sup> It is well-known that BrS follows an autosomal dominant pattern of inheritance. However, so far, only a few pathogenic variants associated with BrS have been reported in these potassium genes.<sup><xref ref-type="bibr" rid="bib47">47</xref></sup>
</p>
<p>One pathogenic variant associated with BrS patients has been located in the <italic>KCNE1L</italic> gene (<italic>KCNE5</italic>) –X-linked gene.<sup><xref ref-type="bibr" rid="bib46">46</xref></sup> Recently, a BrS family carrying a pathogenic variant in the <italic>KCNJ8</italic> gene was also reported. In addition, BrS has also been associated with <italic>HCN4,</italic> which encodes the hyperpolarization-activated cyclic nucleotide-gated potassium channel 4. This is expressed in the sinus node and cells of cardiac conduction system, thus loss of function of HCN4 protein is associated with sinus nodal dysfunction.<sup><xref ref-type="bibr" rid="bib48">48</xref></sup> Finally, the <italic>ABCC9</italic> gene encodes the sulfonylurea receptor subunits SUR2A.<sup><xref ref-type="bibr" rid="bib49">49</xref></sup> Pathogenic variants in this gene induce a gain-of-function in I(K-ATP), and when coupled with a loss-of-function in <italic>SCN5A</italic>, may underlie a severe arrhythmic phenotype.</p>
</sec>
<sec>
<title>Catecholaminergic polymorphic ventricular tachycardia</title>
<p>Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac disorder characterized by adrenergic-induced bi-directional and polymorphic ventricular arrhythmias leading to SCD, mainly in the juvenile population, without structural heart alterations (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The baseline ECG is usually normal, and unfortunately the first presentation can also be SCD.<sup><xref ref-type="bibr" rid="bib50">50</xref></sup>
</p>
<p>Currently, CPVT is known to be caused by impaired intracellular calcium handling due to nearly 200 pathogenic genetic variations in 5 different genes (<italic>RyR2, CASQ2, KCNJ2, CALM1</italic> and <italic>TRDN</italic>) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Focusing on <italic>KCNJ2</italic>, only 3 genetic variants have been associated with CPVT (CM045295, CM066888, and CM066889) to date, but a further variation (CM111211) has been reported in a patient showing Andersen-Tawil syndrome and CPVT mimicry.<sup><xref ref-type="bibr" rid="bib51">51</xref></sup>
</p>
</sec>
</sec>
<sec>
<title>Calcium channels and associated proteins</title>
<p>Calcium channels have been implicated in an increasing number of inherited cardiac arrhythmias allowing activation of the contraction of the heart<sup><xref ref-type="bibr" rid="bib52">52</xref></sup> (<xref ref-type="table" rid="tbl1">Table 1</xref>). Among these, a combination of BrS and shorter QT, LQT syndrome, BrS, SQT syndrome, and CPVT are the main diseases associated with SCD.</p>
<sec>
<title>Combination of Brugada syndrome and shorter QT interval</title>
<p>Genetic variants in <italic>CACNA1C</italic> are responsible for a defective functioning of the type-L calcium channels, inducing a loss of channel function linked to the combination of BrS with shorter QT.<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> Other genetic variants in <italic>CACNB2b</italic> lead to the same ECG traces (combination of BrS and shorter QT).<sup><xref ref-type="bibr" rid="bib53">53</xref></sup>
</p>
</sec>
<sec>
<title>Short QT syndrome</title>
<p>The third calcium gene is <italic>CACNA2D1</italic> and only 1 pathogenic variant has been associated with SQTS (CM111612).<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> However, this variant is currently discussed as pathogenic due to its identification in a control population.</p>
</sec>
<sec>
<title>Long QT syndrome</title>
<p>Some genetic variants in calcium genes associated with LQT syndrome (<italic>CACNA1C, RYR2, CALM1, CALM2</italic> and <italic>ANK2</italic>) have been reported.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> Pathogenic variants in <italic>CACNA1C</italic> cause LQT syndrome Type 8 (Timothy syndrome). This type of long QT syndrome is uncommon, but has the highest associated mortality. The genetic variation induces an enhanced function with I<sub>Ca</sub> abnormality, and loss of the channel dependent voltage, leading to a prolongation of the action potential. This gives rise to an ECG with an extremely long QT interval.<sup><xref ref-type="bibr" rid="bib55">55</xref></sup> Recently, a few cases of LQT syndrome have been identified in two genes: <italic>CALM1</italic> and <italic>CALM2</italic>. <italic>CALM1</italic> and <italic>CALM2</italic>, together with <italic>CALM3</italic>, encode for calmodulin protein. Their products have identical amino acid sequences, and all three are expressed in the human heart left ventricle. Calmodulin is a multifunctional Ca<sup>+2</sup> binding protein essential for transduction of Ca<sup>+2</sup> signals to influence the activity of cardiac ion channels, kinases, and other target proteins in heart.<sup><xref ref-type="bibr" rid="bib56">56</xref></sup> However, association of both these genes with LQT syndrome should be further studied. Finally, LQT syndrome has been associated with <italic>ANK2</italic>, an associated calcium protein.<sup><xref ref-type="bibr" rid="bib57">57</xref></sup> This gene encodes for the Ankyrin-B protein. Ankyrins are adaptor proteins that link membrane proteins, transporters, and cell adhesion molecules to cytoskeleton, including Nav1.5, Na+/Ca+2 exchanger, Na+/K+ ATPase, Kir6.2, and the inositol trisphosphate (IP3) receptor. Variations in ANK2 result in a dysfunctional ankyrin-B, causing a Na+/Ca+2 exchanger and Na+/K+ ATPase dysfunction. This dysfunction leads to an increment of intracellular Na+ and Ca+2 ions, producing cellular early and delayed afterdepolarizations (EADs and DADs, respectively) in response to catecholamine.<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> So far, nearly 20 variations have been identified in the <italic>ANK2</italic> gene.</p>
</sec>
<sec>
<title>BrugadasSyndrome</title>
<p>In 2010, the <italic>CACNA2D1</italic> gene was associated with BrS.<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> So far, no more than 5 genetic variants have been reported. In addition, pathogenic genetic variants have also been reported in the <italic>TRPM4</italic> gene which encodes the transient receptor potential melastatin protein number 4, a calcium-activated nonselective cation channel, and a member of a large family of transient receptor potential genes.<sup><xref ref-type="bibr" rid="bib59">59</xref></sup> Few genetic variants have been published as causative of BrS in this gene, so far.</p>
</sec>
<sec>
<title>Catecholaminergic polymorphic ventricular tachycardia</title>
<p>As previously mentioned, nearly 200 pathogenic genetic variations in 5 different genes (<italic>RyR2, CASQ2, KCNJ2, CALM1</italic> and <italic>TRDN</italic>) have been identified to date. Calcium-related genes are implicated in regulating intracellular calcium, and both types of defect lead to increased function of these proteins, and to an increased outflow of calcium from the sarcoplasmatic reticulum. This excess of calcium is associated with alterations in the sarcolemmal membrane potential leading to late depolarization, which predispose to lethal arrhythmias.<sup><xref ref-type="bibr" rid="bib60">60</xref></sup>
</p>
<p>The main gene associated with CPVT is <italic>RyR2</italic>.<sup><xref ref-type="bibr" rid="bib61">61</xref></sup> The ryanodine receptor is an intracellular calcium channel that is located in the sarcoplasmatic reticulum and activated by the influx of small amounts of calcium, thereby allowing the outflow of stored calcium. This is crucial in triggering heart muscle contraction. One other gene associated with CPVT is <italic>CASQ2</italic> which encodes the cardiac muscle family member of the calsequestrin family that acts as an internal calcium store in muscle cells.<sup><xref ref-type="bibr" rid="bib62">62</xref></sup> Nearly 25 genetic variants have been associated with CPVT showing mainly an autosomal recessive inheritance pattern. Two calcium associated proteins have also been reported in CPVT cases, Calmodulin (<italic>CALM1</italic>)<sup><xref ref-type="bibr" rid="bib63">63</xref></sup> and Triadin (<italic>TRDN</italic>).<sup><xref ref-type="bibr" rid="bib64">64</xref></sup> To date, only two genetic variants have been linked to CPVT (CM128791 and CM128792) in <italic>CALM1</italic>. Recently, a potential association of the <italic>CALM2</italic> gene in overlapping clinical features of LQTS and CPVT has been published, but its pathogenic role remains to be clarified.<sup><xref ref-type="bibr" rid="bib56">56</xref></sup> Finally, Triadin is an integral membrane protein that contains a single transmembrane domain, involved in anchoring Calsequestrin (<italic>CASQ2</italic>) to the junctional sarcoplasmic reticulum and allowing its functional coupling with the Ryanodine receptor (<italic>RyR2</italic>) that regulates sarcoplasmic reticulum calcium release. Currently, 3 genetic variants have been associated with CPVT (CM124195, CM124194, and CD124196).</p>
</sec>
</sec>
<sec>
<title>Conclusions</title>
<p>Cardiology has greatly benefited from the recent progress in genetics, which has helped both to unravel the origin of several cardiac diseases, and to understand their mechanistic pathways. A proportion of this improved genetic understanding has been applied to the diagnosis and prevention of channelopathies associated with SCD. Genetic test have been incorporated into clinical practice to diagnose clinically affected patients, to identify individuals who despite asymptomatic are at risk of SCD, and to unravel the genetic alterations responsible for death in post-mortem cases with no-conclusive cause of death after autopsy. Despite several genes have been reported in ion channel diseases, a large proportion of clinically diagnosed families remain without a recognized genetic cause of disease. Continuing efforts in researching the genetics of SCD will allow us to identify new genetic alterations associated with SCD, improving current diagnostic tests, early prevention, and risk stratification. Finally, all these genetic advances in conjunction with families, clinicians, and basic researchers will be crucial to the advancement of biomedicine towards personalized treatments.</p>
</sec>
</body>
<back>
<fn-group>
<fn id="FN0001">
<p>
<sup><sup>#</sup></sup> Both authors contributed equally</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basso</surname><given-names>C</given-names></name><name><surname>Carturan</surname><given-names>E</given-names></name><name><surname>Pilichou</surname><given-names>K</given-names></name><name><surname>Rizzo</surname><given-names>S</given-names></name><name><surname>Corrado</surname><given-names>D</given-names></name><name><surname>Thiene</surname><given-names>G</given-names></name></person-group>
<article-title>Sudden cardiac death with normal heart molecular autopsy</article-title>
<source/>Cardiovasc Pathol.
<year>2010 Nov-Dec</year>
<volume>19</volume>
<issue>6</issue>
<fpage>321</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">20381381</pub-id></element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name><name><surname>D'Aloja</surname><given-names>E</given-names></name><name><surname>Boschi</surname><given-names>I</given-names></name><name><surname>Partemi</surname><given-names>S</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Pascali</surname><given-names>VL</given-names></name></person-group>
<article-title>State of the art in forensic investigation of sudden cardiac death</article-title>
<source/>Am J Forensic Med Pathol.
<year>2010 Mar</year>
<volume>32</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">20083991</pub-id></element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Allegue</surname><given-names>C</given-names></name><name><surname>Partemi</surname><given-names>S</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>Negative autopsy and sudden cardiac death</article-title>
<source/>International journal of legal medicine.
<year>2014</year>
<volume>128</volume>
<fpage>599</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="pmid">24532175</pub-id></element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wellens</surname><given-names>HJ</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Lindemans</surname><given-names>FW</given-names></name><name><surname>Buxton</surname><given-names>AE</given-names></name><name><surname>Goldberger</surname><given-names>JJ</given-names></name><name><surname>Hohnloser</surname><given-names>SH</given-names></name><name><surname>Huikuri</surname><given-names>HV</given-names></name><name><surname>Kaab</surname><given-names>S</given-names></name><name><surname>La Rovere</surname><given-names>MT</given-names></name><name><surname>Malik</surname><given-names>M</given-names></name><name><surname>Myerburg</surname><given-names>RJ</given-names></name><name><surname>Simoons</surname><given-names>ML</given-names></name><name><surname>Swedberg</surname><given-names>K</given-names></name><name><surname>Tijssen</surname><given-names>J</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name></person-group>
<article-title>Risk stratification for sudden cardiac death: Current status and challenges for the future</article-title>
<source/>Eur Heart J.
<year>2014</year>
<volume>35</volume>
<fpage>1642</fpage>
<lpage>1651</lpage>
<pub-id pub-id-type="pmid">24801071</pub-id></element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arzamendi</surname><given-names>D</given-names></name><name><surname>Benito</surname><given-names>B</given-names></name><name><surname>Tizon-Marcos</surname><given-names>H</given-names></name><name><surname>Flores</surname><given-names>J</given-names></name><name><surname>Tanguay</surname><given-names>JF</given-names></name><name><surname>Ly</surname><given-names>H</given-names></name><name><surname>Doucet</surname><given-names>S</given-names></name><name><surname>Leduc</surname><given-names>L</given-names></name><name><surname>Leung</surname><given-names>TK</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><name><surname>Talajic</surname><given-names>M</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>Increase in sudden death from coronary artery disease in young adults</article-title>
<source/>Am Heart J.
<year>2011</year>
<volume>161</volume>
<fpage>574</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="pmid">21392614</pub-id></element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Sanchez-Molero</surname><given-names>O</given-names></name><name><surname>Allegue</surname><given-names>C</given-names></name><name><surname>Coll</surname><given-names>M</given-names></name><name><surname>Mademont-Soler</surname><given-names>I</given-names></name><name><surname>Selga</surname><given-names>E</given-names></name><name><surname>Ferrer-Costa</surname><given-names>C</given-names></name><name><surname>Mates</surname><given-names>J</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><name><surname>Sarquella-Brugada</surname><given-names>G</given-names></name><name><surname>Cesar</surname><given-names>S</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Castella</surname><given-names>J</given-names></name><name><surname>Medallo</surname><given-names>J</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>Post-mortem genetic analysis in juvenile cases of sudden cardiac death</article-title>
<source/>Forensic Sci Int.
<year>2014</year>
<volume>245C</volume>
<fpage>30</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">25447171</pub-id></element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolpert</surname><given-names>C</given-names></name><name><surname>Parade</surname><given-names>U</given-names></name><name><surname>Herrera-Siklody</surname><given-names>C</given-names></name><name><surname>Strotmann</surname><given-names>C</given-names></name><name><surname>Rub</surname><given-names>N</given-names></name></person-group>
<article-title>[ion channel diseases in children]</article-title>
<source/>Herzschrittmacherther Elektrophysiol.
<year>2014</year>
<volume>25</volume>
<fpage>148</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">25148918</pub-id></element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W</given-names></name></person-group>
<article-title>Clinical and genetic diagnosis for inherited cardiac arrhythmias</article-title>
<source/>Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
<year>2014</year>
<volume>81</volume>
<fpage>203</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">25186574</pub-id></element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Allegue</surname><given-names>C</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>[genetics of sudden unexplained death]</article-title>
<source/>Med clin.
<year>2014</year>
<volume>142</volume>
<fpage>265</fpage>
<lpage>269</lpage>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name><name><surname>Matthews</surname><given-names>GD</given-names></name></person-group>
<article-title>The role of ion channelopathies in sudden cardiac death: Implications for clinical practice</article-title>
<source/>Ann Med.
<year>2013</year>
<volume>45</volume>
<fpage>364</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="pmid">23651009</pub-id></element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giudicessi</surname><given-names>JR</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name></person-group>
<article-title>Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes</article-title>
<source/>Translational research: the journal of laboratory and clinical medicine.
<year>2013</year>
<volume>161</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">22995932</pub-id></element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W</given-names></name></person-group>
<article-title>Update of diagnosis and management of inherited cardiac arrhythmias</article-title>
<source/>Circ J.
<year>2013</year>
<volume>77</volume>
<fpage>2867</fpage>
<lpage>2872</lpage>
<pub-id pub-id-type="pmid">24200848</pub-id></element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Hoeijen</surname><given-names>DA</given-names></name><name><surname>Blom</surname><given-names>MT</given-names></name><name><surname>Tan</surname><given-names>HL</given-names></name></person-group>
<article-title>Cardiac sodium channels and inherited electrophysiological disorders: An update on the pharmacotherapy</article-title>
<source/>Expert Opin Pharmacother.
<year>2014</year>
<volume>15</volume>
<fpage>1875</fpage>
<lpage>1887</lpage>
<pub-id pub-id-type="pmid">24992280</pub-id></element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amin</surname><given-names>AS</given-names></name><name><surname>Pinto</surname><given-names>YM</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name></person-group>
<article-title>Long qt syndrome: Beyond the causal mutation</article-title>
<source/>J Physiol.
<year>2013</year>
<volume>591</volume>
<fpage>4125</fpage>
<lpage>4139</lpage>
<pub-id pub-id-type="pmid">23753525</pub-id></element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizusawa</surname><given-names>Y</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name></person-group>
<article-title>Genetic and clinical advances in congenital long qt syndrome</article-title>
<source/>Circ J.
<year>2014</year>
<volume>78</volume>
<fpage>2827</fpage>
<lpage>2833</lpage>
<pub-id pub-id-type="pmid">25274057</pub-id></element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medeiros-Domingo</surname><given-names>A</given-names></name><name><surname>Kaku</surname><given-names>T</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Iturralde-Torres</surname><given-names>P</given-names></name><name><surname>Itty</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><name><surname>Valdivia</surname><given-names>C</given-names></name><name><surname>Ueda</surname><given-names>K</given-names></name><name><surname>Canizales-Quinteros</surname><given-names>S</given-names></name><name><surname>Tusie-Luna</surname><given-names>MT</given-names></name><name><surname>Makielski</surname><given-names>JC</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name></person-group>
<article-title>Scn4b-encoded sodium channel beta4 subunit in congenital long-qt syndrome</article-title>
<source/>Circulation.
<year>2007</year>
<volume>116</volume>
<fpage>134</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">17592081</pub-id></element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riuro</surname><given-names>H</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Arbelo</surname><given-names>E</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><name><surname>Batlle</surname><given-names>M</given-names></name><name><surname>Perez-Villa</surname><given-names>F</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>GJ</given-names></name><name><surname>Scornik</surname><given-names>FS</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>A missense mutation in the sodium channel beta1b subunit reveals scn1b as a susceptibility gene underlying long qt syndrome</article-title>
<source/>Heart Rhythm.
<year>2014</year>
<volume>11</volume>
<fpage>1202</fpage>
<lpage>1209</lpage>
<pub-id pub-id-type="pmid">24662403</pub-id></element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vatta</surname><given-names>M</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><name><surname>Makielski</surname><given-names>JC</given-names></name><name><surname>Ughanze</surname><given-names>EE</given-names></name><name><surname>Taylor</surname><given-names>EW</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Balijepalli</surname><given-names>RC</given-names></name><name><surname>Foell</surname><given-names>JD</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Kamp</surname><given-names>TJ</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name></person-group>
<article-title>Mutant caveolin-3 induces persistent late sodium current and is associated with long-qt syndrome</article-title>
<source/>Circulation.
<year>2006</year>
<volume>114</volume>
<fpage>2104</fpage>
<lpage>2112</lpage>
<pub-id pub-id-type="pmid">17060380</pub-id></element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Ai</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name><name><surname>Mohapatra</surname><given-names>B</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Abbasi</surname><given-names>S</given-names></name><name><surname>Purevjav</surname><given-names>E</given-names></name><name><surname>Samani</surname><given-names>K</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Qi</surname><given-names>M</given-names></name><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Vatta</surname><given-names>M</given-names></name></person-group>
<article-title>Alpha-1-syntrophin mutation and the long-qt syndrome: A disease of sodium channel disruption</article-title>
<source/>Circ Arrhythm Electrophysiol.
<year>2008</year>
<volume>1</volume>
<fpage>193</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="pmid">19684871</pub-id></element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>R</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Sarquella-Brugada</surname><given-names>G</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name></person-group>
<article-title>Brugada syndrome</article-title>
<source/>Methodist DeBakey cardiovascular journal.
<year>2014</year>
<volume>10</volume>
<fpage>25</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">24932359</pub-id></element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name></person-group>
<article-title>Genetics of brugada syndrome</article-title>
<source/>Curr Opin Cardiol.
<year>2010 May</year>
<volume>25</volume>
<issue>3</issue>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">20224390</pub-id></element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Kirsch</surname><given-names>GE</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name><name><surname>Potenza</surname><given-names>D</given-names></name><name><surname>Moya</surname><given-names>A</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Breithardt</surname><given-names>G</given-names></name><name><surname>Ortiz-Lopez</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>O'Brien</surname><given-names>RE</given-names></name><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group>
<article-title>Genetic basis and molecular mechanism for idiopathic ventricular fibrillation</article-title>
<source/>Nature.
<year>1998</year>
<volume>392</volume>
<fpage>293</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">9521325</pub-id></element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Koopmann</surname><given-names>TT</given-names></name><name><surname>Le Scouarnec</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Ingram</surname><given-names>CR</given-names></name><name><surname>Schott</surname><given-names>JJ</given-names></name><name><surname>Demolombe</surname><given-names>S</given-names></name><name><surname>Probst</surname><given-names>V</given-names></name><name><surname>Anselme</surname><given-names>F</given-names></name><name><surname>Escande</surname><given-names>D</given-names></name><name><surname>Wiesfeld</surname><given-names>AC</given-names></name><name><surname>Pfeufer</surname><given-names>A</given-names></name><name><surname>Kaab</surname><given-names>S</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Hasdemir</surname><given-names>C</given-names></name><name><surname>Aizawa</surname><given-names>Y</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>Bezzina</surname><given-names>CR</given-names></name></person-group>
<article-title>Sodium channel beta1 subunit mutations associated with brugada syndrome and cardiac conduction disease in humans</article-title>
<source/>J Clin Invest.
<year>2008</year>
<volume>118</volume>
<fpage>2260</fpage>
<lpage>2268</lpage>
<pub-id pub-id-type="pmid">18464934</pub-id></element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riuro</surname><given-names>H</given-names></name><name><surname>Beltran-Alvarez</surname><given-names>P</given-names></name><name><surname>Tarradas</surname><given-names>A</given-names></name><name><surname>Selga</surname><given-names>E</given-names></name><name><surname>Campuzano</surname><given-names>O</given-names></name><name><surname>Verges</surname><given-names>M</given-names></name><name><surname>Pagans</surname><given-names>S</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name><name><surname>Vazquez</surname><given-names>FM</given-names></name><name><surname>Perez</surname><given-names>GJ</given-names></name><name><surname>Scornik</surname><given-names>FS</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>A missense mutation in the sodium channel beta2 subunit reveals scn2b as a new candidate gene for brugada syndrome</article-title>
<source/>Hum Mutat.
<year>2013</year>
<volume>34</volume>
<fpage>961</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="pmid">23559163</pub-id></element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Barajas-Martinez</surname><given-names>H</given-names></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Springer</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Pfeiffer</surname><given-names>R</given-names></name><name><surname>Koopmann</surname><given-names>TT</given-names></name><name><surname>Cordeiro</surname><given-names>JM</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>A mutation in the beta 3 subunit of the cardiac sodium channel associated with brugada ecg phenotype</article-title>
<source/>Circ Cardiovasc Genet.
<year>2009</year>
<volume>2</volume>
<fpage>270</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="pmid">20031595</pub-id></element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bezzina</surname><given-names>CR</given-names></name><name><surname>Barc</surname><given-names>J</given-names></name><name><surname>Mizusawa</surname><given-names>Y</given-names></name><name><surname>Remme</surname><given-names>CA</given-names></name><name><surname>Gourraud</surname><given-names>JB</given-names></name><name><surname>Simonet</surname><given-names>F</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Dagradi</surname><given-names>F</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><name><surname>Fressart</surname><given-names>V</given-names></name><name><surname>Leenhardt</surname><given-names>A</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>Bartkowiak</surname><given-names>S</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Schimpf</surname><given-names>R</given-names></name><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Zumhagen</surname><given-names>S</given-names></name><name><surname>Behr</surname><given-names>ER</given-names></name><name><surname>Bastiaenen</surname><given-names>R</given-names></name><name><surname>Tfelt-Hansen</surname><given-names>J</given-names></name><name><surname>Olesen</surname><given-names>MS</given-names></name><name><surname>Kaab</surname><given-names>S</given-names></name><name><surname>Beckmann</surname><given-names>BM</given-names></name><name><surname>Weeke</surname><given-names>P</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Endo</surname><given-names>N</given-names></name><name><surname>Minamino</surname><given-names>T</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Makita</surname><given-names>N</given-names></name><name><surname>Nogami</surname><given-names>A</given-names></name><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Aiba</surname><given-names>T</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Lantieri</surname><given-names>O</given-names></name><name><surname>Torchio</surname><given-names>M</given-names></name><name><surname>Wiese</surname><given-names>C</given-names></name><name><surname>Weber</surname><given-names>D</given-names></name><name><surname>Wolswinkel</surname><given-names>R</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Bezieau</surname><given-names>S</given-names></name><name><surname>Charpentier</surname><given-names>E</given-names></name><name><surname>Chatel</surname><given-names>S</given-names></name><name><surname>Despres</surname><given-names>A</given-names></name><name><surname>Gros</surname><given-names>F</given-names></name><name><surname>Kyndt</surname><given-names>F</given-names></name><name><surname>Lecointe</surname><given-names>S</given-names></name><name><surname>Lindenbaum</surname><given-names>P</given-names></name><name><surname>Portero</surname><given-names>V</given-names></name><name><surname>Violleau</surname><given-names>J</given-names></name><name><surname>Gessler</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>HL</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>Le Marec</surname><given-names>H</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><name><surname>Probst</surname><given-names>V</given-names></name><name><surname>Schott</surname><given-names>JJ</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Redon</surname><given-names>R</given-names></name></person-group>
<article-title>Common variants at scn5a-scn10a and hey2 are associated with brugada syndrome, a rare disease with high risk of sudden cardiac death</article-title>
<source/>Nat Genet.
<year>2013</year>
<volume>45</volume>
<fpage>1044</fpage>
<lpage>1049</lpage>
<pub-id pub-id-type="pmid">23872634</pub-id></element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>London</surname><given-names>B</given-names></name><name><surname>Michalec</surname><given-names>M</given-names></name><name><surname>Mehdi</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Kerchner</surname><given-names>L</given-names></name><name><surname>Sanyal</surname><given-names>S</given-names></name><name><surname>Viswanathan</surname><given-names>PC</given-names></name><name><surname>Pfahnl</surname><given-names>AE</given-names></name><name><surname>Shang</surname><given-names>LL</given-names></name><name><surname>Madhusudanan</surname><given-names>M</given-names></name><name><surname>Baty</surname><given-names>CJ</given-names></name><name><surname>Lagana</surname><given-names>S</given-names></name><name><surname>Aleong</surname><given-names>R</given-names></name><name><surname>Gutmann</surname><given-names>R</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>McNamara</surname><given-names>DM</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Dudley</surname><given-names>SC</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (gpd1-l) decreases cardiac na+ current and causes inherited arrhythmias</article-title>
<source/>Circulation.
<year>2007</year>
<volume>116</volume>
<fpage>2260</fpage>
<lpage>2268</lpage>
<pub-id pub-id-type="pmid">17967977</pub-id></element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kattygnarath</surname><given-names>D</given-names></name><name><surname>Maugenre</surname><given-names>S</given-names></name><name><surname>Neyroud</surname><given-names>N</given-names></name><name><surname>Balse</surname><given-names>E</given-names></name><name><surname>Ichai</surname><given-names>C</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Dilanian</surname><given-names>G</given-names></name><name><surname>Martins</surname><given-names>RP</given-names></name><name><surname>Fressart</surname><given-names>V</given-names></name><name><surname>Berthet</surname><given-names>M</given-names></name><name><surname>Schott</surname><given-names>JJ</given-names></name><name><surname>Leenhardt</surname><given-names>A</given-names></name><name><surname>Probst</surname><given-names>V</given-names></name><name><surname>Le Marec</surname><given-names>H</given-names></name><name><surname>Hainque</surname><given-names>B</given-names></name><name><surname>Coulombe</surname><given-names>A</given-names></name><name><surname>Hatem</surname><given-names>SN</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name></person-group>
<article-title>Mog1: A new susceptibility gene for brugada syndrome</article-title>
<source/>Circ Cardiovasc Genet.
<year>2011</year>
<volume>4</volume>
<fpage>261</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="pmid">21447824</pub-id></element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Marcou</surname><given-names>CA</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>On</surname><given-names>YK</given-names></name><name><surname>Park</surname><given-names>JE</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Hiraoka</surname><given-names>M</given-names></name><name><surname>Nakazawa</surname><given-names>K</given-names></name><name><surname>Sakurada</surname><given-names>H</given-names></name><name><surname>Arimura</surname><given-names>T</given-names></name><name><surname>Makita</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name></person-group>
<article-title>A novel disease gene for brugada syndrome: Sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hnav1.5</article-title>
<source/>Circ Arrhythm Electrophysiol.
<year>2012</year>
<volume>5</volume>
<fpage>1098</fpage>
<lpage>1107</lpage>
<pub-id pub-id-type="pmid">23064965</pub-id></element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cerrone</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Agullo-Pascual</surname><given-names>E</given-names></name><name><surname>Pfenniger</surname><given-names>A</given-names></name><name><surname>Chkourko Gusky</surname><given-names>HN</given-names></name><name><surname>ovelli</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Tirasawadichai</surname><given-names>T</given-names></name><name><surname>Judge</surname><given-names>DP</given-names></name><name><surname>Rothenberg</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>HS</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Delmar</surname><given-names>M</given-names></name></person-group>
<article-title>Missense mutations in plakophilin-2 cause sodium current deficit and associate with a brugada syndrome phenotype</article-title>
<source/>Circulation.
<year>2014</year>
<volume>129</volume>
<fpage>1092</fpage>
<lpage>1103</lpage>
<pub-id pub-id-type="pmid">24352520</pub-id></element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ravens</surname><given-names>U</given-names></name><name><surname>Cerbai</surname><given-names>E</given-names></name></person-group>
<article-title>Role of potassium currents in cardiac arrhythmias</article-title>
<source/>Europace.
<year>2008 Oct</year>
<volume>10</volume>
<issue>10</issue>
<fpage>1133</fpage>
<lpage>1137</lpage>
<pub-id pub-id-type="pmid">18653669</pub-id></element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Behere</surname><given-names>SP</given-names></name><name><surname>Shubkin</surname><given-names>CD</given-names></name><name><surname>Weindling</surname><given-names>SN</given-names></name></person-group>
<article-title>Recent advances in the understanding and management of long qt syndrome</article-title>
<source/>Curr Opin Pediatr.
<year>2014</year>
<volume>26</volume>
<fpage>727</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="pmid">25313972</pub-id></element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aizawa</surname><given-names>Y</given-names></name><name><surname>Ueda</surname><given-names>K</given-names></name><name><surname>Scornik</surname><given-names>F</given-names></name><name><surname>Cordeiro</surname><given-names>JM</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Nagata</surname><given-names>Y</given-names></name><name><surname>Iesaka</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Hiraoka</surname><given-names>M</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>A novel mutation in kcnq1 associated with a potent dominant negative effect as the basis for the lqt1 form of the long qt syndrome</article-title>
<source/>J Cardiovasc Electrophysiol.
<year>2007</year>
<volume>18</volume>
<fpage>972</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="pmid">17655673</pub-id></element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Dennis</surname><given-names>AT</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Ronchetti</surname><given-names>E</given-names></name><name><surname>Bryskin</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name></person-group>
<article-title>Cellular dysfunction of lqt5-mink mutants: Abnormalities of iks, ikr and trafficking in long qt syndrome</article-title>
<source/>Hum Mol Genet.
<year>1999</year>
<volume>8</volume>
<fpage>1499</fpage>
<lpage>1507</lpage>
<pub-id pub-id-type="pmid">10400998</pub-id></element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Spector</surname><given-names>PS</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group>
<article-title>Spectrum of herg k+-channel dysfunction in an inherited cardiac arrhythmia</article-title>
<source/>Proc Natl Acad Sci U S A.
<year>1996</year>
<volume>93</volume>
<fpage>2208</fpage>
<lpage>2212</lpage>
<pub-id pub-id-type="pmid">8700910</pub-id></element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>M</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>Cellular basis for electrocardiographic and arrhythmic manifestations of andersen-tawil syndrome (lqt7)</article-title>
<source/>Heart Rhythm.
<year>2006</year>
<volume>3</volume>
<fpage>328</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="pmid">16500306</pub-id></element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Grunnet</surname><given-names>M</given-names></name><name><surname>Olesen</surname><given-names>SP</given-names></name><name><surname>Rasmussen</surname><given-names>HB</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Jespersen</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name></person-group>
<article-title>Identification of a kir3.4 mutation in congenital long qt syndrome</article-title>
<source/>Am J Hum Genet.
<year>2010</year>
<volume>86</volume>
<fpage>872</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="pmid">20560207</pub-id></element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Marquardt</surname><given-names>ML</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Sampson</surname><given-names>KJ</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Kass</surname><given-names>RS</given-names></name></person-group>
<article-title>Mutation of an a-kinase-anchoring protein causes long-qt syndrome</article-title>
<source/>Proc Natl Acad Sci U S A.
<year>2007</year>
<volume>104</volume>
<fpage>20990</fpage>
<lpage>20995</lpage>
<pub-id pub-id-type="pmid">18093912</pub-id></element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Gussak</surname><given-names>I</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name></person-group>
<article-title>Short qt syndrome: A predictable story</article-title>
<source/>Cardiology.
<year>2014</year>
<volume>128</volume>
<fpage>231</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="pmid">24818800</pub-id></element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazzanti</surname><given-names>A</given-names></name><name><surname>Kanthan</surname><given-names>A</given-names></name><name><surname>Monteforte</surname><given-names>N</given-names></name><name><surname>Memmi</surname><given-names>M</given-names></name><name><surname>Bloise</surname><given-names>R</given-names></name><name><surname>Novelli</surname><given-names>V</given-names></name><name><surname>Miceli</surname><given-names>C</given-names></name><name><surname>O'Rourke</surname><given-names>S</given-names></name><name><surname>Borio</surname><given-names>G</given-names></name><name><surname>Zienciuk-Krajka</surname><given-names>A</given-names></name><name><surname>Curcio</surname><given-names>A</given-names></name><name><surname>Surducan</surname><given-names>AE</given-names></name><name><surname>Colombo</surname><given-names>M</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name></person-group>
<article-title>Novel insight into the natural history of short qt syndrome</article-title>
<source/>J Am Coll Cardiol.
<year>2014</year>
<volume>63</volume>
<fpage>1300</fpage>
<lpage>1308</lpage>
<pub-id pub-id-type="pmid">24291113</pub-id></element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>R</given-names></name><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Dumaine</surname><given-names>R</given-names></name><name><surname>Cordeiro</surname><given-names>J</given-names></name><name><surname>Gaita</surname><given-names>F</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Menendez</surname><given-names>TM</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Wolpert</surname><given-names>C</given-names></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>YS</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Bianchi</surname><given-names>F</given-names></name><name><surname>Giustetto</surname><given-names>C</given-names></name><name><surname>Schimpf</surname><given-names>R</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>Sudden death associated with short-qt syndrome linked to mutations in herg</article-title>
<source/>Circulation.
<year>2004</year>
<volume>109</volume>
<fpage>30</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">14676148</pub-id></element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Piper</surname><given-names>DR</given-names></name><name><surname>Diaz-Valdecantos</surname><given-names>A</given-names></name><name><surname>Brugada</surname><given-names>J</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Santos-de-Soto</surname><given-names>J</given-names></name><name><surname>Grueso-Montero</surname><given-names>J</given-names></name><name><surname>Diaz-Enfante</surname><given-names>E</given-names></name><name><surname>Brugada</surname><given-names>P</given-names></name><name><surname>Sachse</surname><given-names>F</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Brugada</surname><given-names>R</given-names></name></person-group>
<article-title>De novo kcnq1 mutation responsible for atrial fibrillation and short qt syndrome in utero</article-title>
<source/>Cardiovasc Res.
<year>2005</year>
<volume>68</volume>
<fpage>433</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">16109388</pub-id></element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Pandit</surname><given-names>SV</given-names></name><name><surname>Rivolta</surname><given-names>I</given-names></name><name><surname>Berenfeld</surname><given-names>O</given-names></name><name><surname>Ronchetti</surname><given-names>E</given-names></name><name><surname>Dhamoon</surname><given-names>A</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Anumonwo</surname><given-names>J</given-names></name><name><surname>di Barletta</surname><given-names>MRG</given-names></name><name><surname>Gudapakkam</surname><given-names>S</given-names></name><name><surname>Bosi</surname><given-names>G</given-names></name><name><surname>Stramba-Badiale</surname><given-names>M</given-names></name></person-group>
<article-title>A novel form of short qt syndrome (sqt3) is caused by a mutation in the kcnj2 gene</article-title>
<source/>Circ Res.
<year>2005</year>
<volume>96</volume>
<fpage>800</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="pmid">15761194</pub-id></element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giudicessi</surname><given-names>JR</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Mugione</surname><given-names>A</given-names></name><name><surname>Nesterenko</surname><given-names>VV</given-names></name><name><surname>Albertson</surname><given-names>RM</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name></person-group>
<article-title>Transient outward current (i(to)) gain-of-function mutations in the kcnd3-encoded kv4.3 potassium channel and brugada syndrome</article-title>
<source/>Heart Rhythm.
<year>2011</year>
<volume>8</volume>
<fpage>1024</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="pmid">21349352</pub-id></element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Delpon</surname><given-names>E</given-names></name><name><surname>Cordeiro</surname><given-names>JM</given-names></name><name><surname>Nunez</surname><given-names>L</given-names></name><name><surname>Thomsen</surname><given-names>PE</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Kanters</surname><given-names>JK</given-names></name><name><surname>Larsen</surname><given-names>CT</given-names></name><name><surname>Hofman-Bang</surname><given-names>J</given-names></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Christiansen</surname><given-names>M</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>Functional effects of kcne3 mutation and its role in the development of brugada syndrome</article-title>
<source/>Circ Arrhythm Electrophysiol.
<year>2008</year>
<volume>1</volume>
<fpage>209</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="pmid">19122847</pub-id></element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Zankov</surname><given-names>DP</given-names></name><name><surname>Ding</surname><given-names>WG</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Makiyama</surname><given-names>T</given-names></name><name><surname>Doi</surname><given-names>T</given-names></name><name><surname>Shizuta</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>A</given-names></name><name><surname>Naiki</surname><given-names>N</given-names></name><name><surname>Hancox</surname><given-names>JC</given-names></name><name><surname>Matsuura</surname><given-names>H</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name></person-group>
<article-title>Kcne5 (kcne1l) variants are novel modulators of brugada syndrome and idiopathic ventricular fibrillation</article-title>
<source/>Circ Arrhythm Electrophysiol.
<year>2011</year>
<volume>4</volume>
<fpage>352</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">21493962</pub-id></element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medeiros-Domingo</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Eckhardt</surname><given-names>L</given-names></name><name><surname>Cuoretti</surname><given-names>A</given-names></name><name><surname>Kroboth</surname><given-names>SL</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Kopp</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Makielski</surname><given-names>JC</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name></person-group>
<article-title>Gain-of-function mutation s422l in the kcnj8-encoded cardiac k(atp) channel kir6.1 as a pathogenic substrate for j-wave syndromes</article-title>
<source/>Heart Rhythm.
<year>2010</year>
<volume>7</volume>
<fpage>1466</fpage>
<lpage>1471</lpage>
<pub-id pub-id-type="pmid">20558321</pub-id></element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ueda</surname><given-names>K</given-names></name><name><surname>Hirano</surname><given-names>Y</given-names></name><name><surname>Higashiuesato</surname><given-names>Y</given-names></name><name><surname>Aizawa</surname><given-names>Y</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Tana</surname><given-names>T</given-names></name><name><surname>Ohya</surname><given-names>Y</given-names></name><name><surname>Takishita</surname><given-names>S</given-names></name><name><surname>Muratani</surname><given-names>H</given-names></name><name><surname>Hiraoka</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name></person-group>
<article-title>Role of hcn4 channel in preventing ventricular arrhythmia</article-title>
<source/>J Hum Genet.
<year>2009</year>
<volume>54</volume>
<fpage>115</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="pmid">19165230</pub-id></element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Barajas-Martinez</surname><given-names>H</given-names></name><name><surname>Terzic</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Pfeiffer</surname><given-names>R</given-names></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Veltmann</surname><given-names>C</given-names></name><name><surname>Schimpf</surname><given-names>R</given-names></name><name><surname>Cai</surname><given-names>JJ</given-names></name><name><surname>Nam</surname><given-names>GB</given-names></name><name><surname>Deshmukh</surname><given-names>P</given-names></name><name><surname>Scheinman</surname><given-names>M</given-names></name><name><surname>Preminger</surname><given-names>M</given-names></name><name><surname>Steinberg</surname><given-names>J</given-names></name><name><surname>Lopez-Izquierdo</surname><given-names>A</given-names></name><name><surname>Ponce-Balbuena</surname><given-names>D</given-names></name><name><surname>Wolpert</surname><given-names>C</given-names></name><name><surname>Haissaguerre</surname><given-names>M</given-names></name><name><surname>Sanchez-Chapula</surname><given-names>JA</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>Abcc9 is a novel brugada and early repolarization syndrome susceptibility gene</article-title>
<source/>Int J Cardiol.
<year>2014</year>
<volume>171</volume>
<fpage>431</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">24439875</pub-id></element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pflaumer</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>AM</given-names></name></person-group>
<article-title>Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia</article-title>
<source/>Heart Lung Circ.
<year>2012</year>
<volume>21</volume>
<fpage>96</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">22119737</pub-id></element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Mizusawa</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>WG</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Makiyama</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>A</given-names></name><name><surname>Naiki</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Tateno</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Zang</surname><given-names>WJ</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Matsuura</surname><given-names>H</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name></person-group>
<article-title>Phenotype variability in patients carrying kcnj2 mutations</article-title>
<source/>Circ Cardiovasc Genet.
<year>2012</year>
<volume>5</volume>
<fpage>344</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">22589293</pub-id></element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D</given-names></name><name><surname>Bode</surname><given-names>E</given-names></name><name><surname>Venetucci</surname><given-names>L</given-names></name><name><surname>Trafford</surname><given-names>A</given-names></name></person-group>
<article-title>Calcium flux balance in the heart</article-title>
<source/>J Mol Cell Cardiol.
<year>2013</year>
<volume>58</volume>
<fpage>110</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">23220128</pub-id></element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Cordeiro</surname><given-names>JM</given-names></name><name><surname>Casis</surname><given-names>O</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Aizawa</surname><given-names>Y</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Pfeiffer</surname><given-names>R</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Wollnik</surname><given-names>B</given-names></name><name><surname>Gelber</surname><given-names>P</given-names></name><name><surname>Bonaros</surname><given-names>EP</given-names><suffix>Jr</suffix></name><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Sargent</surname><given-names>JD</given-names></name><name><surname>Schickel</surname><given-names>S</given-names></name><name><surname>Oberheiden</surname><given-names>R</given-names></name><name><surname>Bhatia</surname><given-names>A</given-names></name><name><surname>Hsu</surname><given-names>LF</given-names></name><name><surname>Haissaguerre</surname><given-names>M</given-names></name><name><surname>Schimpf</surname><given-names>R</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Wolpert</surname><given-names>C</given-names></name></person-group>
<article-title>Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by st-segment elevation, short qt intervals, and sudden cardiac death</article-title>
<source/>Circulation.
<year>2007</year>
<volume>115</volume>
<fpage>442</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="pmid">17224476</pub-id></element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burashnikov</surname><given-names>E</given-names></name><name><surname>Pfeiffer</surname><given-names>R</given-names></name><name><surname>Barajas-Martinez</surname><given-names>H</given-names></name><name><surname>Delpon</surname><given-names>E</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Haissaguerre</surname><given-names>M</given-names></name><name><surname>Kanter</surname><given-names>R</given-names></name><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Guerchicoff</surname><given-names>A</given-names></name><name><surname>Laino</surname><given-names>R</given-names></name><name><surname>Marieb</surname><given-names>M</given-names></name><name><surname>Nademanee</surname><given-names>K</given-names></name><name><surname>Nam</surname><given-names>GB</given-names></name><name><surname>Robles</surname><given-names>R</given-names></name><name><surname>Schimpf</surname><given-names>R</given-names></name><name><surname>Stapleton</surname><given-names>DD</given-names></name><name><surname>Viskin</surname><given-names>S</given-names></name><name><surname>Winters</surname><given-names>S</given-names></name><name><surname>Wolpert</surname><given-names>C</given-names></name><name><surname>Zimmern</surname><given-names>S</given-names></name><name><surname>Veltmann</surname><given-names>C</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group>
<article-title>Mutations in the cardiac l-type calcium channel associated with inherited j-wave syndromes and sudden cardiac death</article-title>
<source/>Heart Rhythm.
<year>2010</year>
<volume>7</volume>
<fpage>1872</fpage>
<lpage>1882</lpage>
<pub-id pub-id-type="pmid">20817017</pub-id></element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Timothy</surname><given-names>KW</given-names></name><name><surname>Sharpe</surname><given-names>LM</given-names></name><name><surname>Decher</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Bloise</surname><given-names>R</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Joseph</surname><given-names>RM</given-names></name><name><surname>Condouris</surname><given-names>K</given-names></name><name><surname>Tager-Flusberg</surname><given-names>H</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group>
<article-title>Ca(v)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title>
<source/>Cell.
<year>2004</year>
<volume>119</volume>
<fpage>19</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">15454078</pub-id></element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Makita</surname><given-names>N</given-names></name><name><surname>Yagihara</surname><given-names>N</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>CN</given-names></name><name><surname>Beckmann</surname><given-names>BM</given-names></name><name><surname>Roh</surname><given-names>MS</given-names></name><name><surname>Shigemizu</surname><given-names>D</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Aiba</surname><given-names>T</given-names></name><name><surname>Homfray</surname><given-names>T</given-names></name><name><surname>Behr</surname><given-names>ER</given-names></name><name><surname>Klug</surname><given-names>D</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Mastantuono</surname><given-names>E</given-names></name><name><surname>Theisen</surname><given-names>D</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Satake</surname><given-names>W</given-names></name><name><surname>Toda</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Tsuji</surname><given-names>Y</given-names></name><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Endo</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Ozaki</surname><given-names>K</given-names></name><name><surname>Motomura</surname><given-names>H</given-names></name><name><surname>Suda</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Kaab</surname><given-names>S</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Bhuiyan</surname><given-names>ZA</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Chazin</surname><given-names>WJ</given-names></name><name><surname>George</surname><given-names>AL</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Novel calmodulin mutations associated with congenital arrhythmia susceptibility</article-title>
<source/>Circ Cardiovasc Genet.
<year>2014</year>
<volume>7</volume>
<fpage>466</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">24917665</pub-id></element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Schott</surname><given-names>JJ</given-names></name><name><surname>Gramolini</surname><given-names>AO</given-names></name><name><surname>Dilly</surname><given-names>KW</given-names></name><name><surname>Guatimosim</surname><given-names>S</given-names></name><name><surname>duBell</surname><given-names>WH</given-names></name><name><surname>Song</surname><given-names>LS</given-names></name><name><surname>Haurogne</surname><given-names>K</given-names></name><name><surname>Kyndt</surname><given-names>F</given-names></name><name><surname>Ali</surname><given-names>ME</given-names></name><name><surname>Rogers</surname><given-names>TB</given-names></name><name><surname>Lederer</surname><given-names>WJ</given-names></name><name><surname>Escande</surname><given-names>D</given-names></name><name><surname>Le Marec</surname><given-names>H</given-names></name><name><surname>Bennett</surname><given-names>V</given-names></name></person-group>
<article-title>Ankyrin-b mutation causes type 4 long-qt cardiac arrhythmia and sudden cardiac death</article-title>
<source/>Nature.
<year>2003</year>
<volume>421</volume>
<fpage>634</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="pmid">12571597</pub-id></element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohler</surname><given-names>PJ</given-names></name></person-group>
<article-title>Ankyrins and human disease: What the electrophysiologist should know</article-title>
<source/>J Cardiovasc Electrophysiol.
<year>2006</year>
<volume>17</volume>
<fpage>1153</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="pmid">16800854</pub-id></element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stallmeyer</surname><given-names>B</given-names></name><name><surname>Zumhagen</surname><given-names>S</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Duthoit</surname><given-names>G</given-names></name><name><surname>Hebert</surname><given-names>JL</given-names></name><name><surname>Ferrer</surname><given-names>X</given-names></name><name><surname>Maugenre</surname><given-names>S</given-names></name><name><surname>Schmitz</surname><given-names>W</given-names></name><name><surname>Kirchhefer</surname><given-names>U</given-names></name><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name></person-group>
<article-title>Mutational spectrum in the ca(2+)–activated cation channel gene trpm4 in patients with cardiac conductance disturbances</article-title>
<source/>Hum Mutat.
<year>2012</year>
<volume>33</volume>
<fpage>109</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">21887725</pub-id></element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>U</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name></person-group>
<article-title>Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia</article-title>
<source/>J Cardiovasc Electrophysiol.
<year>2007</year>
<volume>18</volume>
<fpage>791</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="pmid">17578347</pub-id></element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>PJ</given-names></name><name><surname>Brown</surname><given-names>KM</given-names></name><name><surname>Piippo</surname><given-names>K</given-names></name><name><surname>Swan</surname><given-names>H</given-names></name><name><surname>Devaney</surname><given-names>JM</given-names></name><name><surname>Brahmbhatt</surname><given-names>B</given-names></name><name><surname>Donarum</surname><given-names>EA</given-names></name><name><surname>Marino</surname><given-names>M</given-names></name><name><surname>Tiso</surname><given-names>N</given-names></name><name><surname>Viitasalo</surname><given-names>M</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name><name><surname>Stephan</surname><given-names>DA</given-names></name><name><surname>Kontula</surname><given-names>K</given-names></name></person-group>
<article-title>Mutations of the cardiac ryanodine receptor (ryr2) gene in familial polymorphic ventricular tachycardia</article-title>
<source/>Circulation.
<year>2001</year>
<volume>103</volume>
<fpage>485</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="pmid">11157710</pub-id></element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lahat</surname><given-names>H</given-names></name><name><surname>Eldar</surname><given-names>M</given-names></name><name><surname>Levy-Nissenbaum</surname><given-names>E</given-names></name><name><surname>Bahan</surname><given-names>T</given-names></name><name><surname>Friedman</surname><given-names>E</given-names></name><name><surname>Khoury</surname><given-names>A</given-names></name><name><surname>Lorber</surname><given-names>A</given-names></name><name><surname>Kastner</surname><given-names>DL</given-names></name><name><surname>Goldman</surname><given-names>B</given-names></name><name><surname>Pras</surname><given-names>E</given-names></name></person-group>
<article-title>Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: Clinical features and assignment of the disease gene to chromosome 1p13-21</article-title>
<source/>Circulation.
<year>2001</year>
<volume>103</volume>
<fpage>2822</fpage>
<lpage>2827</lpage>
<pub-id pub-id-type="pmid">11401939</pub-id></element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marsman</surname><given-names>RF</given-names></name><name><surname>Barc</surname><given-names>J</given-names></name><name><surname>Beekman</surname><given-names>L</given-names></name><name><surname>Alders</surname><given-names>M</given-names></name><name><surname>Dooijes</surname><given-names>D</given-names></name><name><surname>van den Wijngaard</surname><given-names>A</given-names></name><name><surname>Ratbi</surname><given-names>I</given-names></name><name><surname>Sefiani</surname><given-names>A</given-names></name><name><surname>Bhuiyan</surname><given-names>ZA</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><name><surname>Bezzina</surname><given-names>CR</given-names></name></person-group>
<article-title>A mutation in calm1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence</article-title>
<source/>J Am Coll Cardiol.
<year>2014</year>
<volume>63</volume>
<fpage>259</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="pmid">24076290</pub-id></element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roux-Buisson</surname><given-names>N</given-names></name><name><surname>Cacheux</surname><given-names>M</given-names></name><name><surname>Fourest-Lieuvin</surname><given-names>A</given-names></name><name><surname>Fauconnier</surname><given-names>J</given-names></name><name><surname>Brocard</surname><given-names>J</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Durand</surname><given-names>P</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name><name><surname>Kyndt</surname><given-names>F</given-names></name><name><surname>Leenhardt</surname><given-names>A</given-names></name><name><surname>Le Marec</surname><given-names>H</given-names></name><name><surname>Lucet</surname><given-names>V</given-names></name><name><surname>Mabo</surname><given-names>P</given-names></name><name><surname>Probst</surname><given-names>V</given-names></name><name><surname>Monnier</surname><given-names>N</given-names></name><name><surname>Ray</surname><given-names>PF</given-names></name><name><surname>Santoni</surname><given-names>E</given-names></name><name><surname>Tremeaux</surname><given-names>P</given-names></name><name><surname>Lacampagne</surname><given-names>A</given-names></name><name><surname>Faure</surname><given-names>J</given-names></name><name><surname>Lunardi</surname><given-names>J</given-names></name><name><surname>Marty</surname><given-names>I</given-names></name></person-group>
<article-title>Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human</article-title>
<source/>Hum Mol Genet.
<year>2012</year>
<volume>21</volume>
<fpage>2759</fpage>
<lpage>2767</lpage>
<pub-id pub-id-type="pmid">22422768</pub-id></element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" position="float">
<label>Figure 1.</label>
<caption>
<p>Electrocardiograms showing A. Long QT Syndrome B. Brugada Syndrome C. Short QT Syndrome, and D. Catecholaminergic Polymorphic Ventricular Tachycardia.</p>
</caption>
<graphic xlink:href="gcsp.2015.03.039-g001"></graphic>
</fig>
<fig id="fig2" position="float">
<label>Figure 2.</label>
<caption>
<p>Diagram of overlapping genes associated with main cardiac channelopathies. Short QT Syndrome (SQT), Long QT Syndrome (LQT), Brugada Syndrome (BrS), and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).</p>
</caption>
<graphic xlink:href="gcsp.2015.03.039-g002"></graphic>
</fig>
<table-wrap id="tbl1" position="float">
<label>Table 1</label>
<caption>
<p>Overview of ion channel diseases.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Channel</td>
<td align="left" colspan="1" rowspan="1">Disease</td>
<td align="left" colspan="1" rowspan="1">Inheritance</td>
<td align="left" colspan="1" rowspan="1">Gene</td>
<td align="left" colspan="1" rowspan="1">Protein</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Sodium</td>
<td align="left" colspan="1" rowspan="1">LQT 3</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN5A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Nav1.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 10</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN4B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 17</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 1</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN5A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Nav1.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 2</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>GPD1-L</italic>
</td>
<td align="left" colspan="1" rowspan="1">Glycerol-3-P-DH-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 5</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 7</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN3B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 16</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN2B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">Br S 17</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SCN10A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Navβ</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 19</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>PKP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Plakophilin-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sodium-associated</td>
<td align="left" colspan="1" rowspan="1">LQT 9</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CAV3</italic>
</td>
<td align="left" colspan="1" rowspan="1">M-Caveolin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 12</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SNTA1</italic>
</td>
<td align="left" colspan="1" rowspan="1">α-Syntrophin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 10</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>RANGRF</italic>
</td>
<td align="left" colspan="1" rowspan="1">RAN-G-release factor (MOG1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 14</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>SLMAP</italic>
</td>
<td align="left" colspan="1" rowspan="1">Sarcolemma associated protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Potassium</td>
<td align="left" colspan="1" rowspan="1">LQT 1</td>
<td align="left" colspan="1" rowspan="1">AD/AR</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv7.1 hERG/Kv11.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 2</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ2</italic>
</td>
<td align="left" colspan="1" rowspan="1">MinK</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 5</td>
<td align="left" colspan="1" rowspan="1">AD/AR</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNE1</italic>
</td>
<td align="left" colspan="1" rowspan="1">MiRP1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 6</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNE2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv2.1/Kir2.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 7</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNJ5</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv3.4/Kir3.4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 13</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNH2</italic>
</td>
<td align="left" colspan="1" rowspan="1">hERG/Kv11.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">SQT 2</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNQ1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv7.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">SQT 3</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNJ2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv2.1/Kir2.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 6</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNE3</italic>
</td>
<td align="left" colspan="1" rowspan="1">MiRP2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 8</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNJ8</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv6.1/Kir6.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 9</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>HCN4</italic>
</td>
<td align="left" colspan="1" rowspan="1">Hyperpolarization cyclic nucleotide-gated 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 11</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNE5</italic>
</td>
<td align="left" colspan="1" rowspan="1">Potassium voltage-gated channel subfamily E member1 like</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 12</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCND3</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv4.3/Kir4.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">CPVT 3</td>
<td align="left" colspan="1" rowspan="1">Sex-related</td>
<td align="left" colspan="1" rowspan="1">
<italic>KCNJ2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Kv2.1/Kir2.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Potassium-associated</td>
<td align="left" colspan="1" rowspan="1">LQT 11</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>AKAP9</italic>
</td>
<td align="left" colspan="1" rowspan="1">Yotiao</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 18</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>ABCC9</italic>
</td>
<td align="left" colspan="1" rowspan="1">ATP-binding cassette transporter of IK-ATP (SUR2A)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Calcium</td>
<td align="left" colspan="1" rowspan="1">BrS 3/shorter QT (SQT 4)</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1C</italic>
</td>
<td align="left" colspan="1" rowspan="1">Cav1.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 4/shorter QT (SQT 5)</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNB2B</italic>
</td>
<td align="left" colspan="1" rowspan="1">Voltage-dependent β-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 13</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA2D1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Voltage-dependent α2/δ1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">BrS 15</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>TRPM4</italic>
</td>
<td align="left" colspan="1" rowspan="1">Transient receptor potential M4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">SQT 6</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA2D1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Voltage-dependent α2/δ1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 8</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1C</italic>
</td>
<td align="left" colspan="1" rowspan="1">Cav1.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 14</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>RYR2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Ryanodine Receptor 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 15</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CALM1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Calmodulin 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">LQT 16</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CALM2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Calmodulin 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">CPVT 1</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>RYR2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Ryanodine Receptor 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">CPVT 2</td>
<td align="left" colspan="1" rowspan="1">AR</td>
<td align="left" colspan="1" rowspan="1">
<italic>CASQ2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Calsequestrin 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Calcium-associated</td>
<td align="left" colspan="1" rowspan="1">LQT 4</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>ANK2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Ank-B</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">CPVT 4</td>
<td align="left" colspan="1" rowspan="1">AR</td>
<td align="left" colspan="1" rowspan="1">
<italic>TRDN</italic>
</td>
<td align="left" colspan="1" rowspan="1">Triadin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
</td>
<td align="left" colspan="1" rowspan="1">CPVT 5</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<italic>CALM1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Calmodulin 1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AD, Autosomic Dominant; AR, Autosomic Recessive; AF, Atrial Fibrillation; BrS, Brugada Syndrome; CPVT, Catecholaminergic Polymorphic Ventricular Tachycardia; LQT, Long QT Syndrome; SQT, Short QT Syndrome.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>